SC 4-14: Methods to Assess Radiation Risk to Implantable Devices and Uniform Guidance to Users on Risk and Risk Mitigation

is currently a medical physicist with the Banner MD Anderson Cancer Center in Phoenix, Arizona and an adjunct professor at San Diego State University. He received his PhD in experimental particle physics from the University of Washington and subsequently completed a post-doctoral fellowship in radiation therapy medical physics at the University of Washington with research in intensity modulated radiation therapy. He has been chief medical physicist at the Veterans Affairs (VA) Puget Sound Health Care System in Seattle and an affiliate faculty member in the University of Washington School of Medicine, a professor at the University of California San Diego and a medical physicist with Landauer Medical Physics. Dr. Sutlief worked to advance radiation therapy within the VA, including agency-wide radiotherapy equipment modernization, radiotherapy device interconnectivity, consultation for the VA National Health Physics Program, participation in several investigations, and development of qualification standards for therapeutic medical physicists. He has coauthored more than 50 articles and book chapters related to therapeutic medical physics. Dr. Sutlief developed and taught the physics curriculum for the Bellevue College Medical Dosimetry program. He has served as a consultant to the International Atomic Energy Agency and as a member of the Radiation Oncology planning group for the Integrating the Healthcare Enterprise. Dr. Sutlief was a Co-organizer for the AAPM Summer School on Quality and Safety in Radiation Therapy and was a faculty member for the Veterans Health Administration Biennial Conference on Radiation Oncology. He actively participates in the American Association of Physicists in Medicine, where he has served on many committees and on several task group reports. He is currently an NCRP Council member.

is a Professor of Radiation Oncology at Brown Medical School in Providence and a clinical medical physicist with internationally-recognized expertise in brachytherapy dosimetry. He has championed this treatment modality within the American Association of Physicists in Medicine, the American Brachytherapy Society, the American Society for Radiation Oncology, and the European Society for Radiotherapy and Oncology through numerous board appointments, committee assignments, and task group chairmanships. Dr. Rivard serves on radiotherapy editorial boards in leadership roles specific to clinical medical physics, and has received substantial extramural support for his various research programs. Through these efforts, he has innovated several medical devices for advancing patient care.

is a cardiologist and cardiac imager at Columbia University Irving Medical Center and New York-Presbyterian Hospital. He is a tenured professor of medicine, with appointments in the Departments of Medicine and Radiology, and serves as Director of Nuclear Cardiology, Cardiac Computed Tomography (CT), and Cardiac Magnetic Resonance Imaging (MRI) and Director of the Advanced Cardiac Imaging Fellowship. Born and raised in New Jersey, Dr. Einstein received an AB in mathematics from Princeton University and attended Mount Sinai School of Medicine, where he received an MD as well as a PhD in the Department of Biomathematical Sciences. He also received an MS in patient-oriented research/biostatistics from Columbia's Mailman School of Public Health. After internship and residency in internal medicine at Rutgers Robert Wood Johnson Medical School, he completed cardiology fellowship training at Mount Sinai.

Dr. Einstein’s clinical activities are centered on cardiovascular positron emission tomography, single-photon emission computerized tomography, CT, and MRI, and he serves as an attending clinical cardiologist caring for patients with a range of cardiovascular diseases including coronary artery disease, heart failure, valvular heart disease, and arrhythmias. His research, which uses each of these imaging modalities, focuses on improving the use of imaging in cardiovascular medicine, with particular interests and funded projects in radiological protection, amyloidosis, COVID-19, machine learning, and device development. It is funded by multiple National Institutes of Health (NIH) grants, the International Atomic Energy Agency, and industry. Dr. Einstein is the author or coauthor of over 300 papers and abstracts, in journals including the New England Journal of Medicine, Journal of the American Medical Association, and Lancet. This work has been influential in affecting clinical practice, and has been widely reported in the popular media and cited over 15,000 times in the scientific literature. For it, Dr. Einstein received the Society of Nuclear Medicine and Molecular Imaging’s 2022 Hermann Blumgart Award, the American College of Cardiology's Douglas P. Zipes Distinguished Young Scientist Award, and the Lewis Katz Cardiovascular Research Prize for a Young Investigator. Dr. Einstein is a Council Member of NCRP, chair of the Academic Cardiology Section of the American College of Cardiology, and a member of the boards of directors of the American Society of Nuclear Cardiology and the Cardiovascular Council of the Society of Nuclear Medicine and Molecular Imaging. He serves as a member of the Nuclear Regulatory Commission’s Advisory Committee for the Medical Use of Isotopes, on the editorial boards of Journal of the American College of Cardiology: Cardiovascular Imaging and the Journal of Nuclear Cardiology, and served as a voting member of the Food and Drug Administration’s Medical Imaging Drugs Advisory Committee, on several NIH study sections, and as a co-author of the International Commission on Radiological Protection Publication 120 on radiological protection in cardiology. Dr. Einstein has served as a mentor to over 40 trainees at stages ranging from high school to junior faculty.

is an Imaging Medical Physicist and Associate Professor at the University of Colorado School of Medicine in Aurora, Colorado. Dr. Marsh is a graduate of the University of Texas Graduate School of Biomedical Sciences in Houston, Texas, and completed her imaging residency at M.D. Anderson Cancer Center. She is certified by the American Board of Radiology in Diagnostic Medical Physics.

Dr. Marsh participates in a wide range of volunteer activities with the American Association of Physicists in Medicine and the American Board of Radiology. Currently, she provides clinical services for x-ray-based imaging modalities and has a specific interest in promoting sensibility in the practice of clinical medical physics. Her primary professional goal is to help provide healthcare professionals and patients with accurate and consistent information about radiation risk from diagnostic imaging procedures.

is the Director of the Medical and Health Physics Program at Louisiana State University in Baton Rouge, holder of the Dr. Charles M. Smith Chair in Medical Physics, and Chief of Physics at the Mary Bird Perkins Cancer Center. He is a board certified and licensed medical physicist with specialization in advanced-technology radiotherapies. Dr. Newhauser is an expert in proton radiation therapy, dose reconstructions, and risk estimation and reduction. His current research projects seek to improve long-term outcomes of survivors of childhood and adult cancers. He and his multidisciplinary team of collaborators are known for their early use of Monte-Carlo methods and high-performance computing in proton therapy, including neutron shielding, treatment planning, and estimation of stray radiation exposures. He received the Innovation Excellence Award in 2012 in recognition of his laboratory's research involving in-silico clinical trials to compare advanced-technology radiotherapies.

Dr. Newhauser has published more than 85 peer-reviewed journal articles, leads federal research grants, and mentors graduate students and post-doctoral fellows. He has served in leadership roles in the American Association of Physicists in Medicine, the American Nuclear Society, and the Health Physics Society. He serves on the International Advisory Board of the journal Physics In Medicine and Biology and is a corresponding member of EURODOS. After receiving a BS in nuclear engineering and MS and PhD degrees medical physics from the University of Wisconsin, he worked at the German National Standards Laboratory, Harvard Medical School and Massachusetts General Hospital, and The University of Texas MD Anderson Cancer Center.